Researchers broaden the attack on Parkinson's disease.
Barinapa
M
M
D000818:Animals; D016380:Brain Tissue Transplantation; D002454:Cell Differentiation; D002490:Central Nervous System / Q000166:cytology / Q000196:embryology; D004298:Dopamine / Q000096:biosynthesis*; D004627:Embryonic Induction; D016332:Fetal Tissue Transplantation; D016222:Fibroblast Growth Factor 2 / Q000096:biosynthesis*; D005818:Genetic Engineering; D051100:Glial Cell Line-Derived Neurotrophic Factor; D006085:Graft Survival; D006801:Humans; D008636:Mesencephalon / Q000166:cytology / Q000196:embryology; D009414:Nerve Growth Factors / Q000627:therapeutic use; D009419:Nerve Tissue Proteins / Q000627:therapeutic use*; D009474:Neurons / Q000166:cytology / Q000378:metabolism* / Q000637:transplantation; D010300:Parkinson Disease / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D051381:Rats
C495039:GDNF protein, human; C495041:Gdnf protein, rat; D051100:Glial Cell Line-Derived Neurotrophic Factor; D009414:Nerve Growth Factors; D009419:Nerve Tissue Proteins; D016222:Fibroblast Growth Factor 2; D004298:Dopamine